Prevencio is a developer of multi-proteomic biomarkers designed to revolutionize blood tests for cardiovascular disease.
Prevencio's investors include MedTech Innovator.
Prevencio is headquartered in Kirkland, United States.
Prevencio is a developer of multi-proteomic biomarkers designed to revolutionize blood tests for cardiovascular disease.
Prevencio is at the Non-equity Assistance stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Prevencio — Funding & Investors." VCBacked, May 29, 2024, https://www.vcbacked.co/company/prevencio. Accessed July 22, 2026.
VCBacked. (2024). Prevencio — Funding & Investors. Retrieved July 22, 2026, from https://www.vcbacked.co/company/prevencio
{{cite web |title=Prevencio — Funding & Investors |url=https://www.vcbacked.co/company/prevencio |website=VCBacked |access-date=July 22, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated